Dmg Group, LLC Pfizer Inc Transaction History

Dmg Group, LLC

$121 Million
Q3 2024

A detailed history of Dmg Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Dmg Group, LLC holds 17,028 shares of PFE stock, worth $453,285. This represents 0.41% of its overall portfolio holdings.

Number of Shares

17,028

Previous 18,019 5.5%

Holding current value

$453,285

Previous $504,000 2.38%

% of portfolio

0.41%

Previous 0.43%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	SELL	$27.7 - $31.39 $27,450 - $31,107	-991 Reduced 5.5%	17,028 $492,000
Q2 2024 Jul 16, 2024	SELL	$25.26 - $29.6 $49,913 - $58,489	-1,976 Reduced 9.88%	18,019 $504,000
Q1 2024 Apr 19, 2024	SELL	$25.89 - $29.73 $3,572 - $4,102	-138 Reduced 0.69%	19,995 $554,000
Q4 2023 Jan 10, 2024	SELL	$26.13 - $33.94 $99,450 - $129,175	-3,806 Reduced 15.9%	20,133 $579,000
Q3 2023 Oct 26, 2023	BUY	$32.09 - $37.51 $27,725 - $32,408	864 Added 3.74%	23,939 $794,000
Q2 2023 Jul 13, 2023	BUY	$36.12 - $41.79 $17,229 - $19,933	477 Added 2.11%	23,075 $846,000
Q1 2023 Apr 24, 2023	BUY	$39.39 - $51.28 $51,837 - $67,484	1,316 Added 6.18%	22,598 $934,000
Q4 2022 Feb 06, 2023	BUY	$41.75 - $54.5 $69,847 - $91,178	1,673 Added 8.53%	21,282 $1.09 Million
Q3 2022 Oct 27, 2022	SELL	$43.76 - $53.42 $10,283 - $12,553	-235 Reduced 1.18%	19,609 $866,000
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $31,593 - $37,460	679 Added 3.54%	19,844 $1.04 Million
Q1 2022 Apr 25, 2022	SELL	$45.75 - $56.69 $254,553 - $315,423	-5,564 Reduced 22.5%	19,165 $922,000
Q4 2021 Jan 31, 2022	BUY	$41.32 - $61.25 $1.02 Million - $1.51 Million	24,729 New	24,729 $1.32 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dmg Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dmg Group, LLC with notifications on news.

Account